Already in the past, many inhibitors targeting ACLY have been investigated in vitro and in vivo for different cancer types, including hydroxycitrate, radicicol, deoxychlorate, vanadate and others (for a review about the mechanistical action, see [234,235]). This evidence concerns the gene ACLY and cancer.